KR100619228B1 - 국소피부전달 무수조성물 및 상기 조성물을 약제로 포함하는 국소 피부 치료용 조성물 - Google Patents
국소피부전달 무수조성물 및 상기 조성물을 약제로 포함하는 국소 피부 치료용 조성물 Download PDFInfo
- Publication number
- KR100619228B1 KR100619228B1 KR1020007008442A KR20007008442A KR100619228B1 KR 100619228 B1 KR100619228 B1 KR 100619228B1 KR 1020007008442 A KR1020007008442 A KR 1020007008442A KR 20007008442 A KR20007008442 A KR 20007008442A KR 100619228 B1 KR100619228 B1 KR 100619228B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- anhydrous
- weight
- amount
- anhydrous composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
케토코나졸/데소나이드 제제 | |
성분 | %w/w |
케토코나졸 | 0 - 2 |
데소나이드 | 0.0 - 0.05 |
프로필렌 글리콜 | 20 |
폴리에틸렌 글리콜 | 20 |
글리세린 | 20 |
PPG-15 스테아릴 에테르 | 0 - 2 |
하이드록시프로필 셀룰로오스 | 1.5 - 2.0 |
아스코르브산 | 0.0 - 0.3 |
구연산 | 0.0 - 0.1 |
부틸화 하이드록시톨루엔 | 0.0 - 0.1 |
에탄올 충분량(q.s.) | 100 |
케토코나졸/데소나이드 제제 | |
성분 | %w/w |
케토코나졸 | 0 - 2 |
데소나이드 | 0.0 - 0.05 |
프로필렌 글리콜 | 10 |
스테아릴 알코올 | 4 |
세틸 알코올 | 4 |
소르비탄 모노스테아레이트 | 2 |
폴리소르베이트 60 | 1.5 |
광물성 오일 | 1 |
이염기 소듐 포스페이트 | 0.25 |
구연산 | 0.24 |
벤조산 | 0.2 |
부틸화 하이드록시아니솔 | 0.005 |
정제수 | 100 |
케토코나졸/데소나이드 제제 | |
성분 | %w/w |
케토코나졸 | 0 - 2 |
데소나이드 | 0 - 0.05 |
프로필렌 글리콜 | 20 |
폴리에틸렌 글리콜 | 10 |
글리세린 | 30 |
PPG-15 스테아릴 에테르 | 2 |
하이드록시프로필 셀룰로오스 | 1.5 - 2.0 |
아스코르브산 | 0 - 0.3 |
구연산 | 0 - 0.1 |
부틸화 하이드록시톨루엔 | 0 - 0.1 |
에탄올 충분량(q.s.) | 100 |
케토코나졸/데소나이드 제제 | |
성분 | %w/w |
케토코나졸 | 0 - 2 |
데소나이드 | 0.0 - 0.05 |
프로필렌 글리콜 | 20 |
N-메틸-2-피롤리돈 | 20 |
글리세린 | 20 |
PPG-15 스테아릴 에테르 | 2 |
하이드록시프로필 셀룰로오스 | 1.5 - 2.0 |
아스코르브산 | 0.0 - 0.3 |
구연산 | 0.0 - 0.1 |
부틸화 하이드록시톨루엔 | 0.0 - 0.1 |
에탄올 충분량(q.s.) | 100 |
트레티노인 제제 | |
성분 | %w/w |
트레티노인 | 0.05 |
프로필렌 글리콜 | 20 |
폴리에틸렌 글리콜 | 20 |
글리세린 | 20 |
PPG-15 스테아릴 에테르 | 0 - 2 |
하이드록시프로필 셀룰로오스 | 1.5 - 2.0 |
구연산 | 0 - 0.15 |
부틸화 하이드록시톨루엔 | 0 - 0.1 |
에탄올 충분량(q.s.) | 100 |
에리쓰로마이신 제제 | |
성분 | %w/w |
에리쓰로마이신 | 2 |
프로필렌 글리콜 | 20 |
폴리에틸렌 글리콜 | 20 |
글리세린 | 20 |
PPG-15 스테아릴 에테르 | 0 - 2 |
하이드록시프로필 셀룰로오스 | 1.5 - 2.0 |
구연산 | 0 - 0.5 |
에탄올 충분량(q.s.) | 100 |
피부 항염증 작용 | ||
% 데소나이드 | 실시예 4 % 억제 ED50(%) | 비교예 4 % 억제 ED50(%) |
0.0000 | 0 0.0015 | 0 0.0054 |
0.0003 | 30.40 | 15.36 |
0.003 | 57.43 | 39.05 |
0.03 | 87.08 | 74.79 |
피부 항균 작용 | ||
P. ovale의 깨끗한 영역 | T. rubrum의 깨끗한 영역 | |
실시예 5 | 11 mm | 13 mm |
비교예 5A | 3 mm | 0 |
비교예 5B | 3 | 0 |
피부로의 케토코나졸 목표 전달(targeted delivery) | ||||
실시예 | 제제 | 표피(epidermis) | 진피(dermis) | 수용체(receptor) |
6B | 2% 케토코나졸, 0.05% (데소나이드) | 0.33±0 | 0.55±0 | 0.2±0 |
6C | (2% 케토코나졸 크림) | 0.64±0.0 | 1.18±0.0 | 0.12±0.0 |
테스트 2 | ||||
6 | (2% 케토코나졸, 0.05% 데소나이드) | 2.44±0.65 | 1.24±0.78 | 0.5±0.05 |
6A | (2% 케토코나졸 크림) | 0.205±0.01 | 0.371±0.10 | 1.017±0.24 |
테스트 3 | ||||
6D | (2% 케토코나졸, 0.05% 데소나이드) | 1.83±0.37 | 1.77±1.01 | 0.950±0.43 |
6E | (2% 케토코나졸 크림) | 0.112±0.03 | 0.195±0.08 | 0.428±0.15 |
피부로의 데소나이드 목표 전달 | ||||
실시예 | 제제 | 표피 | 진피 | 수용체 |
7A | (2% 케토코나졸, 0.05% 데소나이드) | 2.64±0 | 1.85±0 | 1.6±0 |
7B | (0.05% 데소나이드 크림) | 2.57±0 | 2.03±0 | 2.99±0 |
테스트 2 | ||||
7 | (2% 케토코나졸, 0.05% 데소나이드) | 1.222±1.35 | 1.125±0.88 | 0.677±0.06 |
7C | (0.05% 데소나이드 크림) | 1.372±0.21 | 0.718±0.43 | 12.49±1.83 |
테스트 3 | ||||
7D | (2% 케토코나졸, 0.05% 데소나이드) | 1.359±0.44 | 1.905±1.09 | 0.516±0.1 |
7E | (2% 데소나이드 크림) | 0.853±0.03 | 0.104±0.31 | 3.677±1.24 |
누적 자극 테스트(매일 결합된 홍반과 부종 스코어) | |||||
일자 | 0 | 5 | 10 | 15 | 19 |
실시예 8 | 0 | 1.6 | 2.6 | 1.8 | 0.7 |
비교예 8A | 0 | 2.4 | 3.5 | 3.1 | 1.3 |
비교예 8B | 0 | 2.5 | 3.9 | 3.1 | 1.5 |
Claims (52)
- 국소 전달용 겔(gel)로 제조된 무수 조성물로서,(a) 에탄올 (ethanol)과,(b) 프로필렌 글리콜과,(c) 폴리에틸렌 글리콜과,(d) 글리세린과,(e) 케토코나졸 (ketoconazole)를포함하는, 무수 조성물.
- 삭제
- 삭제
- 제 1항에 있어서, 상기 케타코나졸의 양은 전체 조성물 100 중량%를 기준으로 0.5 내지 3 중량%인, 무수 조성물.
- 제 1항에 있어서, 상기 케타코나졸의 양은 전체 조성물 100 중량%를 기준으로 2 중량%인, 무수 조성물.
- 삭제
- 제 1항에 있어서, 상기 에탄올의 양은 전체 조성물 100 중량%를 기준으로 1 내지 50 중량%인, 무수 조성물.
- 삭제
- 제 1항에 있어서, 상기 폴리에틸렌 글리콜의 양은 전체 조성물 100 중량%를 기준으로 10 내지 80 중량%인, 무수 조성물.
- 제 9항에 있어서, 상기 폴리에틸렌 글리콜의 양은 전체 조성물 100 중량%를 기준으로 20 중량%인, 무수 조성물.
- 제 1항에 있어서, 상기 폴리에틸렌 글리콜의 양은 전체 조성물 100 중량%를 기준으로 1 내지 50 중량%인, 무수 조성물.
- 제 11항에 있어서, 상기 폴리에틸렌 글리콜의 양은 전체 조성물 100 중량%를 기준으로 20 중량%인, 무수 조성물.
- 제 1항에 있어서, 상기 글리세린의 양은 전체 조성물 100 중량%를 기준으로 10 내지 80 중량%인, 무수 조성물.
- 제 13항에 있어서, 상기 글리세린의 양은 전체 조성물 100 중량%를 기준으로 20 중량%인, 무수 조성물.
- 삭제
- 삭제
- 제 1항에 있어서, 상기 조성물은 PPG-15 스테아릴 에테르를 더 포함하는, 무수 조성물.
- 제 17항에 있어서, 상기 PPG-15 스테아릴 에테르는 전체 조성물 100 중량%를 기준으로 0 내지 2 중량%인, 무수 조성물.
- 제 18항에 있어서, 상기 PPG-15 스테아릴 에테르는 전체 조성물 100 중량%를 기준으로 2 중량%인, 무수 조성물.
- 삭제
- 삭제
- 제 1항에 있어서, 상기 조성물은 하이드록시프로필 셀룰로오스를 더 포함하는, 무수 조성물.
- 제 22항에 있어서, 상기 하이드록시프로필 셀룰로오스의 양은 전체 조성물 100 중량%를 기준으로 1.5 내지 2 중량%인, 무수 조성물.
- 삭제
- 삭제
- 제 1항에 있어서, 상기 조성물은 아스코르브산, 구연산 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 것을 더 포함하는, 무수 조성물.
- 제 26항에 있어서, 상기 아스코르브산의 양은 전체 조성물 100 중량%를 기준으로 0 내지 0.3 중량%인, 무수 조성물.
- 제 26항에 있어서, 상기 구연산의 양은 전체 조성물 100 중량%를 기준으로 0 내지 0.5 중량%인, 무수 조성물.
- 삭제
- 삭제
- 제 1항에 있어서, 상기 조성물은 아스코르브산, 부틸화 하이드록시 톨루엔, 부틸화 하이드록시아니솔 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 것을 더 포함하는, 무수 조성물.
- 제 31항에 있어서, 상기 부틸화 하이드록시 톨루엔의 양은 전체 조성물 100 중량%를 기준으로 0 내지 0.1 중량%인, 무수 조성물.
- 삭제
- 제 1항에 있어서, 상기 조성물은 글루코코르티코스테로이드 (glucocorticosteroid)를 더 포함하는, 무수 조성물.
- 제 34항에 있어서, 상기 글루코코르티코스테로이드는 데소나이드 (desonide)인, 무수 조성물.
- 제 35항에 있어서, 상기 데소나이드의 양은 전체 조성물 100 중량%를 기준으로 0.0001 내지 10 중량%인, 무수 조성물.
- 제 36항에 있어서, 상기 데소나이드의 양은 전체 조성물 100 중량%를 기준으로 0.02 내지 0.1 중량%인, 무수 조성물.
- 제 1항에 있어서, 상기 조성물은 착색제 (colorant)를 더 포함하는, 무수 조성물.
- 국소 전달용 겔(gel)로 제조된 무수 조성물로서,(a) 프로필렌 글리콜과,(b) 폴리에틸렌 글리콜과,(c) 글리세린과,(d) 에탄올과,(e) 케토코나졸과,(f) PPG-15 스테아릴 에테르와,(g) 하이드록시프로필 셀룰로오스와,(h) 아스코르브산과,(i) 부틸화 하이드록시톨루엔과,(j) 구연산을포함하는, 무수 조성물.
- 제 39항에 있어서, 상기 조성물은 데소나이드를 더 포함하는, 무수 조성물.
- 국소 전달용 겔(gel)로 제조된 무수 조성물로서,(a) 프로필렌 글리콜과,(b) 폴리에틸렌 글리콜과,(c) 글리세린과,(d) 에탄올과,(e) 케토코나졸과,(f) PPG-15 스테아릴 에테르와,(g) 하이드록시프로필 셀룰로오스와,(h) 아스코르브산과,(i) 부틸화 하이드록시톨루엔과,(j) 구연산(k) 착색제로필수 구성된, 무수 조성물.
- 국소 전달용 겔(gel)로 제조된 무수 조성물로서,(a) 프로필렌 글리콜과,(b) 폴리에틸렌 글리콜과,(c) 글리세린과,(d) 에탄올과,(e) 케토코나졸과,(f) PPG-15 스테아릴 에테르와,(g) 하이드록시프로필 셀룰로오스와,(h) 아스코르브산과,(i) 부틸화 하이드록시톨루엔과,(j) 구연산(k) 착색제와,(l) 데소나이드로필수 구성된, 무수 조성물.
- 삭제
- 삭제
- 삭제
- 제 1항 또는 제 39항 내지 제 42항 중 어느 한 항의 조성물 유효량을 포함하는, 포유동물의 피부 진균성 질병 치료용 무수 조성물.
- 삭제
- 제 46항에 있어서, 상기 피부 진균성 질병은 T. rubrum 또는 P. ovale와 관련된, 포유동물의 피부 진균성 질병 치료용 무수 조성물.
- 제 48항에 있어서, 상기 피부의 진균성 질병은 티네아 코르포리스 (tinea corporis), 티네아 크루리스 (tinea cruris), 티네아 페디스 (tinea pedis) 및 지루 피부염 (seborrheic dermatitis)으로 이루어진 그룹으로부터 선택된, 포유동물의 피부 진균성 질병 치료용 무수 조성물.
- 삭제
- 제 1항 또는 제 39항 내지 제 42항 중 어느 한 항의 조성물 유효량은 포유동물의 T. rubrum 또는 P. ovale의 성장을 억제하는 치료용 무수 조성물.
- 제 51항에 있어서, 상기 포유류는 인간인, 포유동물의 T. rubrum 또는 P. ovale의 성장을 억제하는 치료용 무수조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/205,474 | 1998-12-04 | ||
US09/205,474 US6238683B1 (en) | 1998-12-04 | 1998-12-04 | Anhydrous topical skin preparations |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010040573A KR20010040573A (ko) | 2001-05-15 |
KR100619228B1 true KR100619228B1 (ko) | 2006-09-04 |
Family
ID=22762331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020007008442A KR100619228B1 (ko) | 1998-12-04 | 1999-12-03 | 국소피부전달 무수조성물 및 상기 조성물을 약제로 포함하는 국소 피부 치료용 조성물 |
Country Status (18)
Country | Link |
---|---|
US (1) | US6238683B1 (ko) |
EP (2) | EP1645287A3 (ko) |
JP (1) | JP4610741B2 (ko) |
KR (1) | KR100619228B1 (ko) |
CN (2) | CN1204923C (ko) |
AR (1) | AR021539A1 (ko) |
AT (1) | ATE318148T1 (ko) |
AU (2) | AU778524B2 (ko) |
BR (1) | BR9907666A (ko) |
CA (1) | CA2319515C (ko) |
CY (1) | CY1105450T1 (ko) |
DE (1) | DE69930004T2 (ko) |
DK (1) | DK1051193T3 (ko) |
ES (1) | ES2258347T3 (ko) |
HK (1) | HK1031342A1 (ko) |
PT (1) | PT1051193E (ko) |
TW (1) | TW590777B (ko) |
WO (1) | WO2000033877A1 (ko) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7179475B1 (en) | 1998-12-04 | 2007-02-20 | Johnson & Johnson Consumer Companies, Inc. | Anhydrous topical skin preparations |
US6713414B1 (en) | 2000-05-04 | 2004-03-30 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6579570B1 (en) * | 2000-05-04 | 2003-06-17 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6423804B1 (en) | 1998-12-31 | 2002-07-23 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive hard water dispersible polymers and applications therefor |
EP1263415A4 (en) * | 2000-03-03 | 2003-05-02 | Australian Imp Ers Ltd | MICRONIZED VITAMIN C PREPARATION |
US7101563B1 (en) | 2000-03-03 | 2006-09-05 | Australian Importers, Ltd. | Micronized vitamin C formulation |
US6537663B1 (en) | 2000-05-04 | 2003-03-25 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive hard water dispersible polymers and applications therefor |
US6835678B2 (en) | 2000-05-04 | 2004-12-28 | Kimberly-Clark Worldwide, Inc. | Ion sensitive, water-dispersible fabrics, a method of making same and items using same |
US6429261B1 (en) | 2000-05-04 | 2002-08-06 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6683143B1 (en) | 2000-05-04 | 2004-01-27 | Kimberly Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6599848B1 (en) | 2000-05-04 | 2003-07-29 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6548592B1 (en) | 2000-05-04 | 2003-04-15 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6444214B1 (en) | 2000-05-04 | 2002-09-03 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6410036B1 (en) | 2000-05-04 | 2002-06-25 | E-L Management Corp. | Eutectic mixtures in cosmetic compositions |
US6653406B1 (en) | 2000-05-04 | 2003-11-25 | Kimberly Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US7897559B2 (en) * | 2000-06-29 | 2011-03-01 | Parks L Dean | Dermatological composition and kit containing avermectin compound for treating dermatological conditions |
AU2001274420A1 (en) * | 2000-07-11 | 2002-01-21 | Micio Pharma Chemical Ag | Anhydrous pharmaceutical composition of vancomycin for topical use |
US6475526B1 (en) * | 2001-06-05 | 2002-11-05 | Jeffrey B. Smith | Zinc containing compositions for anti-viral use |
US20030199488A1 (en) * | 2002-04-23 | 2003-10-23 | Trotta Gina M. | Treatment of hyperproliferative disorders/inflammatory dermatoses |
MXPA04010889A (es) * | 2002-05-01 | 2005-07-14 | Johnson & Johnson | Composiciones antimicoticas en gel lubricantes, generadoras de calor y no irritantes. |
US7005408B2 (en) * | 2002-05-01 | 2006-02-28 | Mcneil-Ppc, Inc. | Warming and nonirritating lubricant compositions and method of comparing irritation |
US7772138B2 (en) | 2002-05-21 | 2010-08-10 | Kimberly-Clark Worldwide, Inc. | Ion sensitive, water-dispersible polymers, a method of making same and items using same |
US7157389B2 (en) * | 2002-09-20 | 2007-01-02 | Kimberly-Clark Worldwide, Inc. | Ion triggerable, cationic polymers, a method of making same and items using same |
US7101456B2 (en) * | 2002-09-20 | 2006-09-05 | Kimberly-Clark Worldwide, Inc. | Ion triggerable, cationic polymers, a method of making same and items using same |
US20040058600A1 (en) * | 2002-09-20 | 2004-03-25 | Bunyard W. Clayton | Water-dispersible, cationic polymers, a method of making same and items using same |
US6994865B2 (en) * | 2002-09-20 | 2006-02-07 | Kimberly-Clark Worldwide, Inc. | Ion triggerable, cationic polymers, a method of making same and items using same |
US7141519B2 (en) * | 2002-09-20 | 2006-11-28 | Kimberly-Clark Worldwide, Inc. | Ion triggerable, cationic polymers, a method of making same and items using same |
US6960371B2 (en) * | 2002-09-20 | 2005-11-01 | Kimberly-Clark Worldwide, Inc. | Water-dispersible, cationic polymers, a method of making same and items using same |
EP1567113A4 (en) * | 2002-10-24 | 2006-11-08 | G & R Pharmaceuticals Llc | ANTIFUNGAL PREPARATIONS |
US7241456B2 (en) * | 2002-10-25 | 2007-07-10 | Australian Importers Ltd. | Formulations for topical delivery of bioactive substances and methods for their use |
US20080274209A1 (en) * | 2002-11-04 | 2008-11-06 | Integritas Pharma, Inc. | Methods of treating inflammation |
US20060229258A1 (en) * | 2003-07-30 | 2006-10-12 | Daniela Serikaku | Steroidal compositions containing hydroxycarboxylic acids and methods of using the same |
WO2005063207A1 (ja) * | 2003-12-26 | 2005-07-14 | Hisamitsu Pharmaceutical Co., Inc. | 外用非水系ゲル製剤 |
US7854943B2 (en) * | 2004-06-24 | 2010-12-21 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
CA2570599C (en) * | 2004-06-24 | 2012-03-27 | Idexx Laboratories, Inc. | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
US7858115B2 (en) * | 2004-06-24 | 2010-12-28 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
US7618651B2 (en) * | 2004-06-24 | 2009-11-17 | Idexx Laboratories | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
EP3556401A1 (en) | 2005-05-27 | 2019-10-23 | The University of North Carolina at Chapel Hill | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
WO2007041230A2 (en) * | 2005-09-30 | 2007-04-12 | Omp, Inc. | Stable ascorbic acid compositions |
US20070269534A1 (en) * | 2006-02-02 | 2007-11-22 | Ramirez Jose E | Methods of treating skin to enhance therapeutic treatment thereof |
US20070178058A1 (en) * | 2006-02-02 | 2007-08-02 | Ramirez Jose E | Methods of using stable ascorbic acid compositions |
US20080146672A1 (en) * | 2006-12-08 | 2008-06-19 | Denton Marcia Marye | Topical Eutectic Anesthetic Composition for Oral or Dermal Tissue |
FR2931661B1 (fr) * | 2008-05-30 | 2010-07-30 | Galderma Res & Dev | Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide. |
CA2770683C (en) * | 2009-08-14 | 2018-09-04 | Berg Biosystems, Llc | Vitamin d3 and analogs thereof for treating alopecia |
EP2467173B8 (en) | 2009-08-21 | 2019-06-19 | Novan, Inc. | Wound dressings, methods of using the same and methods of forming the same |
ES2958410T3 (es) | 2009-08-21 | 2024-02-08 | Novan Inc | Geles tópicos |
BR112012013812A2 (pt) | 2009-12-08 | 2018-05-29 | Healthpoint Ltd | "composições para desbridamento enzimático de feridas com atividade enzimática melhorada" |
US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
WO2012118829A2 (en) | 2011-02-28 | 2012-09-07 | Novan, Inc. | Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same |
CA2834710A1 (en) * | 2011-05-16 | 2012-11-22 | Dale L. Pearlman | Compositions and methods for the treatment of skin diseases |
WO2013006613A1 (en) | 2011-07-05 | 2013-01-10 | Novan, Inc. | Methods of manufacturing topical compositions and apparatus for same |
WO2013006608A1 (en) | 2011-07-05 | 2013-01-10 | Novan, Inc. | Topical compositions |
US9439940B2 (en) * | 2011-07-19 | 2016-09-13 | Neville Pharmaceutical, Inc. | Topical transdermal method for delivering nutrients through the skin for expeditied wound healing and skin rejuvenation |
US9855211B2 (en) * | 2013-02-28 | 2018-01-02 | Novan, Inc. | Topical compositions and methods of using the same |
US10322082B2 (en) | 2014-07-11 | 2019-06-18 | Novan, Inc. | Topical antiviral compositions and methods of using the same |
EP3698775A1 (en) | 2014-07-11 | 2020-08-26 | Novan Inc. | Topical antiviral compositions and methods of using the same |
JP6899845B2 (ja) | 2016-04-13 | 2021-07-07 | ノヴァン,インコーポレイテッド | 感染症を治療するための組成物、システム、キットおよび方法 |
CA3049402A1 (en) * | 2017-01-06 | 2018-07-12 | Palvella Therapeutics Llc | Anhydrous compositions of mtor inhibitors and methods of use |
CN111148491B (zh) * | 2017-09-21 | 2023-04-07 | 宝洁公司 | 吸收制品 |
EP3817743A4 (en) | 2018-07-02 | 2022-07-06 | Palvella Therapeutics, Inc. | ANHYDROUS COMPOSITIONS OF MTOR INHIBITORS AND METHODS OF USE |
KR102219279B1 (ko) | 2018-09-06 | 2021-02-24 | 경동산업(주) | 분배기를 가공하는 방법 |
KR20200028242A (ko) | 2018-09-06 | 2020-03-16 | 경동산업(주) | 분배기와, 분배기를 가공하는 장치 |
KR102165478B1 (ko) | 2018-10-24 | 2020-10-14 | 경동산업(주) | 냉풍 건조장치 |
US11938004B2 (en) | 2019-05-31 | 2024-03-26 | The Procter & Gamble Company | Absorbent article having a waist gasketing element |
KR102240394B1 (ko) | 2019-07-09 | 2021-04-14 | 경동산업(주) | 저온 냉동 창고의 냉장과 제상 동시 운전 시스템 |
EP4054549A4 (en) * | 2019-11-06 | 2023-12-06 | Smartech Topical, Inc. | TOPICAL FORMULATIONS OF CYCLO-OXYGENASE INHIBITORS AND THEIR USE |
WO2021226034A1 (en) | 2020-05-05 | 2021-11-11 | The Procter & Gamble Company | Absorbent articles including improved elastic panels |
AT524069A1 (de) | 2020-07-30 | 2022-02-15 | Hans L Malzl | System und verfahren zur erfassung der schlafqualität |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998010742A1 (en) * | 1996-09-13 | 1998-03-19 | Johnson & Johnson Consumer Products | Composition base for topical therapeutic and cosmetic preparations |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3729568A (en) | 1969-09-23 | 1973-04-24 | Johnson & Johnson | Acne treatment |
US3943013A (en) * | 1973-10-11 | 1976-03-09 | General Electric Company | Triac with gold diffused boundary |
US3934028A (en) | 1974-04-22 | 1976-01-20 | The Regents Of The University Of California | Acne and psoriasis treatment with retinoic acid analogs |
SE7612936L (sv) | 1976-11-19 | 1978-05-20 | Pharmacia Ab | Hygienisk-kosmetiska kompositioner |
US4247547A (en) | 1979-03-19 | 1981-01-27 | Johnson & Johnson | Tretinoin in a gel vehicle for acne treatment |
US4491588A (en) | 1982-03-31 | 1985-01-01 | University Of Tennessee Research Corporation | Treatment of psoriasis and seborrheic dermatitis with imidazole antibiotics |
US4942162A (en) | 1982-03-31 | 1990-07-17 | University Of Tennessee Research Corporation | Topical treatment of seborrheic dermatitis with ketoconazole |
US4569935A (en) | 1983-03-17 | 1986-02-11 | University Of Tennessee Research Corp. | Topical treatment of psoriasis with imidazole antibiotics |
JPS62292716A (ja) * | 1986-06-11 | 1987-12-19 | Kao Corp | 消炎軟膏剤 |
US4782059A (en) | 1986-09-29 | 1988-11-01 | Merck & Co., Inc. | Method of controlling mycotic infections and compositions therefor |
WO1988006041A1 (en) * | 1987-02-23 | 1988-08-25 | Shiseido Company Ltd. | Percutaneous absorption promoter and dermatologic preparation for external use |
US5110809A (en) | 1988-03-21 | 1992-05-05 | Bristol-Myers Squibb Company | Antifungal gel formulations |
US5002938A (en) | 1988-03-21 | 1991-03-26 | Bristol-Myers Squibb Company | Antifungal gel formulations |
US4855294A (en) | 1988-09-06 | 1989-08-08 | Theratech, Inc. | Method for reducing skin irritation associated with drug/penetration enhancer compositions |
US4996193A (en) * | 1989-03-03 | 1991-02-26 | The Regents Of The University Of California | Combined topical and systemic method of administration of cyclosporine |
US4988697A (en) | 1989-07-28 | 1991-01-29 | Merck & Co., Inc. | Fungicidal compositions and method |
US5061700A (en) * | 1989-11-16 | 1991-10-29 | Gordon Jay Dow | Glyceryl acetate ointment vehicles |
US5583136A (en) | 1990-01-29 | 1996-12-10 | Johnson & Johnson Consumer Products, Inc. | Retinoid containing skin care compositions containing imidazoles |
US5087620A (en) | 1990-05-17 | 1992-02-11 | Bristol-Myers Squibb Co. | Controlled dermal penetration enhancement using imidazoles |
US5407663A (en) | 1991-04-11 | 1995-04-18 | Eisen; Drore | Method of treating inflammatory conditions of the mouth using steroid containing mouthwash which may contain antifungal agents |
US5310545A (en) | 1991-04-11 | 1994-05-10 | Drore Eisen | Method of treatment using mouthwashes containing steroids and antifungal agents and compositions of matter |
FR2676052B1 (fr) * | 1991-05-02 | 1994-04-29 | Cird Galderma | Nouveaux composes polycycliques aromatiques et leur utilisation en medecine humaine ou veterinaire et en cosmetique. |
US5208015A (en) | 1991-07-23 | 1993-05-04 | Bristol-Myers Squibb Company | Topical anti-fungal agents having anti-inflammatory activity |
WO1994016710A1 (en) | 1993-01-21 | 1994-08-04 | Janssen Pharmaceutica N.V. | Topical ketoconazole compositions |
TW297813B (ko) | 1993-09-24 | 1997-02-11 | Takeda Pharm Industry Co Ltd | |
US5456851A (en) | 1994-04-07 | 1995-10-10 | Johnson & Johnson Consumer Products, Inc. | Ketoconazole shampoo containing butylated hydroxytoluene or butylated hydroxyanisole |
TW460296B (en) * | 1994-09-01 | 2001-10-21 | Janssen Pharmaceutica Nv | Topical ketoconazole emulsion compositions without sodium sulfite |
EP0729745A1 (en) * | 1995-02-28 | 1996-09-04 | Unilever Plc | Vitamin C delivery system |
-
1998
- 1998-12-04 US US09/205,474 patent/US6238683B1/en not_active Expired - Lifetime
-
1999
- 1999-12-03 DK DK99961929T patent/DK1051193T3/da active
- 1999-12-03 EP EP05077996A patent/EP1645287A3/en not_active Withdrawn
- 1999-12-03 AU AU18412/00A patent/AU778524B2/en not_active Expired
- 1999-12-03 PT PT99961929T patent/PT1051193E/pt unknown
- 1999-12-03 JP JP2000586367A patent/JP4610741B2/ja not_active Expired - Lifetime
- 1999-12-03 CN CNB998036560A patent/CN1204923C/zh not_active Expired - Fee Related
- 1999-12-03 WO PCT/US1999/028661 patent/WO2000033877A1/en active IP Right Grant
- 1999-12-03 EP EP99961929A patent/EP1051193B1/en not_active Expired - Lifetime
- 1999-12-03 AR ARP990106172A patent/AR021539A1/es unknown
- 1999-12-03 BR BR9907666-7A patent/BR9907666A/pt not_active Application Discontinuation
- 1999-12-03 AT AT99961929T patent/ATE318148T1/de active
- 1999-12-03 ES ES99961929T patent/ES2258347T3/es not_active Expired - Lifetime
- 1999-12-03 CA CA002319515A patent/CA2319515C/en not_active Expired - Lifetime
- 1999-12-03 DE DE69930004T patent/DE69930004T2/de not_active Expired - Lifetime
- 1999-12-03 CN CNB2005100650867A patent/CN100341578C/zh not_active Expired - Lifetime
- 1999-12-03 KR KR1020007008442A patent/KR100619228B1/ko active IP Right Grant
-
2000
- 2000-01-21 TW TW088121127A patent/TW590777B/zh not_active IP Right Cessation
-
2001
- 2001-03-28 HK HK01102266A patent/HK1031342A1/xx not_active IP Right Cessation
-
2005
- 2005-03-09 AU AU2005201042A patent/AU2005201042A1/en not_active Abandoned
-
2006
- 2006-04-13 CY CY20061100516T patent/CY1105450T1/el unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998010742A1 (en) * | 1996-09-13 | 1998-03-19 | Johnson & Johnson Consumer Products | Composition base for topical therapeutic and cosmetic preparations |
Non-Patent Citations (1)
Title |
---|
1020007008442 - 590520 |
Also Published As
Publication number | Publication date |
---|---|
CA2319515A1 (en) | 2000-06-15 |
AU1841200A (en) | 2000-06-26 |
CN1714869A (zh) | 2006-01-04 |
CY1105450T1 (el) | 2010-04-28 |
PT1051193E (pt) | 2006-06-30 |
CN1204923C (zh) | 2005-06-08 |
DE69930004T2 (de) | 2006-10-12 |
DE69930004D1 (de) | 2006-04-27 |
CA2319515C (en) | 2009-10-13 |
KR20010040573A (ko) | 2001-05-15 |
ATE318148T1 (de) | 2006-03-15 |
HK1031342A1 (en) | 2001-06-15 |
EP1645287A2 (en) | 2006-04-12 |
TW590777B (en) | 2004-06-11 |
CN100341578C (zh) | 2007-10-10 |
CN1292707A (zh) | 2001-04-25 |
DK1051193T3 (da) | 2006-06-12 |
US6238683B1 (en) | 2001-05-29 |
AU2005201042A1 (en) | 2005-04-07 |
JP2002531526A (ja) | 2002-09-24 |
EP1051193B1 (en) | 2006-02-22 |
JP4610741B2 (ja) | 2011-01-12 |
AU778524B2 (en) | 2004-12-09 |
ES2258347T3 (es) | 2006-08-16 |
BR9907666A (pt) | 2000-12-19 |
AR021539A1 (es) | 2002-07-24 |
EP1051193A1 (en) | 2000-11-15 |
EP1645287A3 (en) | 2006-06-07 |
WO2000033877A1 (en) | 2000-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100619228B1 (ko) | 국소피부전달 무수조성물 및 상기 조성물을 약제로 포함하는 국소 피부 치료용 조성물 | |
US8735393B2 (en) | Anhydrous topical skin preparations | |
EP1562531B1 (en) | Topical skin care composition | |
EP3435973B1 (en) | Apremilast pharmaceutical compositions | |
US20160287614A1 (en) | Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic | |
CN105263469B (zh) | 包含比马前列素的局部组合物和利用其刺激毛发生长的方法 | |
US20210000741A1 (en) | Pharmaceutical compositions comprising silica microspheres | |
US9572777B2 (en) | Topical pharmaceutical composition comprising nanonized silver sulfadiazine | |
CN108283620A (zh) | 一种磷酸二酯酶-4抑制剂的局部药物组合物及其制备方法 | |
EP3065702B1 (en) | Topical pharmaceutical composition of acitretin | |
US10123970B2 (en) | Topical retinoid solutions | |
EP1159956B1 (en) | Anhydrous topical skin preparations | |
MXPA00007720A (en) | Anhydrous topical skin preparations | |
EP1700597B1 (en) | Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application | |
WO2016133471A1 (en) | A topical composition comprising mupirocin and dexpanthenol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120727 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130729 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140730 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160629 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170629 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180628 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190624 Year of fee payment: 14 |